An aerial photo of the Whitney Park estate. Long Lake’s financial picture blossomed unexpectedly this winter as the historic lumber town found out it is designated as the sole beneficiary of all ...

Eli Lilly and Company launched its weight loss drug Mounjaro in India on Thursday after obtaining approval from the Central Drugs Standard Control Organisation (CDSCO). This is a drug which ...

US pharma major Eli Lilly on Thursday launched the much-awaited diabetes and obesity management drug Mounjaro in India at one-fifth of US price. Lilly launched the drug in a single dose vial following ...

With diabetes and obesity cases surging in India, pharmaceutical giant Eli Lilly and Company (India) has launched Mounjaro (tirzepatide), a once-weekly injectable drug for chronic weight ...

The following is the full text of the March 20, 2025 address by former hostage Eli Sharabi at the UN Security Council in New York City. My name is Eli Sharabi. I am 53 years old. I’ve come ...

Tirzepatide was evaluated in two robust global clinical development programs. (Image Credits: Pexels) Eli Lilly and Company (India) on Thursday announced the launch of Mounjaro in single-dose vial ...

“Kelly proving once again that she is the best vocalist since Whitney,” one YouTube commenter wrote. “I had the highest of expectations, and she somehow managed to surpass them. Legend ...

Eli Sharabi, who survived Hamas captivity and whose family was murdered during the October 7th Massacre, arrived at the United Nations in New York where he will brief the ambassadors of the ...

Follow Bloomberg India on WhatsApp for exclusive content and analysis on what billionaires, businesses and markets are doing. Sign up here. Eli Lilly and Co. has begun selling its blockbuster ...

Lilly beats Novo Nordisk to launch weight-loss drug in India Mounjaro's 5 mg vial priced at around $50, 2.5 mg at about $40 Drug's pricing may limit accessibility in India, analyst says Novo's ...

Eli Lilly has launched its diabetes and weight-loss drug Mounjaro in India after receiving regulatory approval. With rising obesity and diabetes rates, India presents a significant market opportunity ...